Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Evidence Study to Support Label Expansion for the NeuroPace RNS System for Drug-Resistant Focal Epilepsy in Adolescent Patients in the United States

NCT07823465 is registered in ClinicalTrials.gov with NeuroPace as lead sponsor.

NCT NCT07823465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07823465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Evidence Study to Support Label Expansion for the NeuroPace RNS System for Drug-Resistant Focal Epilepsy in Adolescent Patients in the United States
Lead sponsor
NeuroPace
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 14, 2026
Completion date
May 31, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-resistant focal epilepsy, focal epilepsy